Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients

NCT06729099 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06729099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06729099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
June 30, 2027
Enrollment
128 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, estrogen receptor-positive